Difference between revisions of "Timeline of Schistosomiasis Control Initiative"
From Timelines
(→How the timeline was built) |
|||
Line 67: | Line 67: | ||
===How the timeline was built=== | ===How the timeline was built=== | ||
− | The initial version of the timeline was written by [[User: | + | The initial version of the timeline was written by [[User:Sebastian]]. |
{{funding info}} is available. | {{funding info}} is available. |
Revision as of 11:34, 12 March 2019
This is a timeline of FIXME.
Contents
Big picture
Time period | Development summary | More details |
---|
Full timeline
Year | Month and date | Event type | Details | Location |
---|---|---|---|---|
2002 | SCI is founded through a US$32 million grant from the Bill and Melinda Gates Foundation,[1], to tackle schistosomiasis in sub-Saharan Africa, where infected people are unable to afford the drugs needed for treatment.[2] | |||
2003 | "SCI has worked in Uganda since 2003 "[1] | |||
2006 | ": In 2006, SCI received large grants from USAID and the Gates Foundation to support integrated NTD programs in eight countries for five years to treat lymphatic filariasis, onchocerciasis, and trachoma, in addition to schistosomiasis and STH"[1] | |||
2007 | "SCI received a grant in 2007 to expand its work to Rwanda and Burundi."[1] | |||
2010 | "SCI began working in Côte d'Ivoire in 2010, but mapping and treatments did not begin until 2012 due to political turmoil."[1] | |||
2010 | "In 2010, SCI received £10.5 million64 (plus separate funding for drugs) from UK's Department for International Development for treating schistosomiasis and STH65 in eight countries over five years."[1] | |||
2010 | October | "In 2010, SCI received £10.5 million64 (plus separate funding for drugs) from DFID for treating schistosomiasis and STH65 in eight countries over five years."[3][1] | ||
2012 | "SCI began working in Côte d'Ivoire in 2010, but mapping and treatments did not begin until 2012 due to political turmoil."[1] | |||
2012 | " SCI began conversations with the government of Ethiopia about starting a national schistosomiasis treatment program in 2012. "[1] | |||
2012 | SCI reaches median coverage for schistosomiasis treatment at 77% in Malawi.[4] | |||
2013 | "SCI began conversations with the government of Ethiopia about starting a national schistosomiasis treatment program in 2012. In 2013, it funded planning for the program"[1] | |||
2013 | SCI begins first round of treatment in Ethiopia.[1] | |||
2013 – 2014 | Between November 2013 and April 2014 | SCI funds mapping in Ethiopia.[1] | ||
2014 | ". Starting in 2014, SCI began working with other partners in Côte d'Ivoire, including Sightsavers, the END Fund, and Helen Keller International on a more integrated neglected tropical diseases (NTD) program."[1] | |||
2014 | "In 2014, UK's Department for International Development awarded SCI an additional £16.6 million over four and a half years (June 2014 to December 2018) to extend the program and expand it to an additional two countries."[1] | |||
2014 | ACI reaches median coverage for schistosomiasis treatment at 69% in Malawi, 82% in Côte d'Ivoire, and 47% in Uganda.[4] | |||
2014 – 2015 | "SCI expected to fund about 4.9 million treatments during its 2014-15 budget year;4 it reported delivering 3.1 million treatments in Côte d'Ivoire in that period"[1] | |||
2015 | ACI reaches median coverage for schistosomiasis treatment at 81% in Mozambique, 93% in Zambia (2015), and 80% in Zanzibar.[4] | |||
2015 – 2016 | " During its 2015-16 budget year, SCI planned to deliver around 0.6 million treatments and reported delivering 1.4 million treatments in Côte d'Ivoire"[1] | |||
2015 – 2016 | Between April 2015 and March 2016 | "SCI spent around $2.1 million in unrestricted funding and $0.8 million in restricted funding in Ethiopia between April 2015 and March 2016."[1] | ||
2015 – 2016 | "Between April 2015 and March 2016, SCI reports that it delivered 890,000 treatments in Uganda; 1.2 million treatments were planned"[1] | |||
2016 | January | "Good Ventures awarded a grant of $1,000,000 to the Schistosomiasis Control Initiative (SCI) for general operating support in January 2016, in recognition of the organization’s earning a “top charity” ranking from GiveWell in 2015. See GiveWell’s review of SCI for more about its activities and to follow its progress."[5] | ||
2016 | August | "GiveWell estimates that programs supported by SCI can deworm a person for approximately $1.26 based (including the estimated cost of SCI’s funding to country programs, SCI’s headquarters costs, cost of donated drugs, and local government involvement)."[4] | ||
2017 | January | "Good Ventures awarded a grant of $13,500,000 to the Schistosomiasis Control Initiative (SCI) for general operating support in January 2017, in recognition of its earning a “top charity” ranking from GiveWell in 2016."[6] |
Meta information on the timeline
How the timeline was built
The initial version of the timeline was written by User:Sebastian.
Funding information for this timeline is available.
Feedback and comments
Feedback for the timeline can be provided at the following places:
- FIXME
What the timeline is still missing
Timeline update strategy
See also
External links
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 "Schistosomiasis Control Initiative: Supplementary Information". givewell.org. Retrieved 11 March 2019.
- ↑ "Ten million Africans treated by international disease treatment programme". imperial.ac.uk. Retrieved 12 March 2019.
- ↑ "Imperial initiative to protect children from tropical disease awarded £25m government backing". imperial.ac.uk. Retrieved 11 March 2019.
- ↑ 4.0 4.1 4.2 4.3 "SCHISTOSOMIASIS CONTROL INITIATIVE". givingwhatwecan.org. Retrieved 12 March 2019.
- ↑ "Schistosomiasis Control Initiative — General Support (2016)". openphilanthropy.org. Retrieved 11 March 2019.
- ↑ "Schistosomiasis Control Initiative — General Support (2017)". openphilanthropy.org. Retrieved 11 March 2019.